Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.66% | 196.94 | 1.3% | $565.97m | |
| GILD | Gilead Sciences, Inc. | 0.70% | 66.42 | 0.9% | $368.71m | |
| BIIB | Biogen Inc. | 1.35% | 238.79 | 1.3% | $340.32m | |
| ILMN | Illumina, Inc. | 1.43% | 309.57 | 3.5% | $338.07m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.62% | 106.32 | 2.0% | $332.28m | |
| CELG | Celgene Corporation | 0.42% | 99.37 | 1.3% | $309.99m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.40% | 295.87 | 2.6% | $188.33m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.12% | 178.12 | 1.9% | $186.01m | |
| A | Agilent Technologies, Inc. | -0.18% | 77.93 | 1.6% | $185.14m | |
| EXAS | Exact Sciences Corporation | 0.55% | 103.97 | 24.1% | $152.91m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.34% | 82.51 | 14.6% | $139.60m | |
| ACAD | ACADIA Pharmaceuticals Inc. | -2.26% | 40.74 | 13.9% | $129.03m | |
| INCY | Incyte Corporation | 3.96% | 81.21 | 2.5% | $93.98m | |
| ALDR | Alder Biopharmaceuticals, Inc. | -0.11% | 18.64 | 10.2% | $81.98m | |
| BMRN | BioMarin Pharmaceutical Inc. | -1.38% | 74.95 | 4.3% | $76.08m |
Company Profile
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.